Indian equities are likely to be impacted on Monday, December 16, with GIFT Nifty futures trading 66 points lower at 24,774.
On Friday, the market closed on a strong note. The BSE Sensex rose by 843 points (1.04%) to 82,133.12, and Nifty50 gained 219 points (0.89%) to close at 24,768.30.
Reliance Industries has acquired a 74% equity stake in Navi Mumbai IIA Private Limited for ₹1,628 crore. The remaining 26% stake will remain with CIDCO, consolidating RIL’s presence in key infrastructure projects.
Dixon Technologies has signed a binding term sheet with Vivo India for a joint venture. The partnership aims to strengthen Dixon’s OEM business, particularly in the manufacturing of smartphones and other electronic devices.
Lupin has acquired 3 trademarks from Boehringer Ingelheim, namely Gibtulio, Gibtulio Met, and Ajaduo, to enhance its diabetes portfolio. The transfer of these trademarks is expected to be completed by March 2025.
CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has received a positive opinion from EMA for its biosimilar Zefylti. The product is used to treat neutropenia and mobilize peripheral progenitor cells.
Afcons Infrastructure has secured a ₹1,007 crore contract from MP Metro Rail Corporation for the development of a metro rail project.
RITES has bagged a ₹297.67 crore contract from the Ministry of External Affairs for the construction of an Integrated Check Post. The project is expected to be completed over 59 months.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Published on: Dec 16, 2024, 8:49 AM IST
We're Live on WhatsApp! Join our channel for market insights & updates